Moreover, we identified CD39+ resting Treg cells and CD28 on secreting Treg cells as risk factors for CRC, consistent with previous findings that increased accumulation of Treg cells is often associated with CRC progression, metastasis, immune therapy failure, and poor prognosis (46–49). The gene discussed is CD28; the disease is colorectal carcinoma.